LDL oxidative modifications in well- or moderately controlled type 2 diabetes.
Scheffer PG, Henry RM, Wever EJ, van Rooij GJ, Bos G, Heine RJ, Dekker JM, Diamant M, Stehouwer CD, Nijpels G, Blankenstein MA, Teerlink T.
Scheffer PG, et al.
Diabetes Metab Res Rev. 2004 Jul-Aug;20(4):298-304. doi: 10.1002/dmrr.461.
Diabetes Metab Res Rev. 2004.
PMID: 15250032